Related Experiment Videos
Anti-tuberculosis activity of quassinoids
S Rahman1, N Fukamiya, M Okano
1Department of Interdisciplinary Studies on Natural Environment, Faculty of Integrated Arts and Sciences, Hiroshima University, Japan.
Chemical & Pharmaceutical Bulletin
|October 23, 1997
Summary
Fifty-six quassinoids from Simaroubaceous plants were evaluated for anti-tuberculosis activity. Shinjulactone K, ailanthone, shinjudilactone, and dehydrobruceantin showed the most potent activity, revealing structure-activity relationships.
Area of Science:
- Natural Products Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Tuberculosis remains a significant global health challenge, necessitating novel therapeutic agents.
- Quassinoids, a class of natural compounds, have demonstrated diverse biological activities.
- Simaroubaceous plants are a rich source of quassinoids with potential medicinal properties.
Purpose of the Study:
- To evaluate the in vitro anti-tuberculosis activity of fifty-six quassinoids.
- To identify potent anti-tuberculosis compounds from selected Simaroubaceous plants.
- To investigate the structure-activity relationships of these quassinoids against Mycobacterium tuberculosis.
Main Methods:
- Isolation of fifty-six quassinoids from four Simaroubaceous plants: Ailanthus altissima, Brucea antidysenterica, Picrasma ailanthoides, and Brucea javanica.
- In vitro anti-tuberculosis activity screening of the isolated compounds.
- Analysis of structure-activity relationships based on the observed activity data.
Main Results:
- Four quassinoids, shinjulactone K (1), ailanthone (2), shinjudilactone (3), and dehydrobruceantin (4), exhibited the most potent anti-tuberculosis activity among the tested compounds.
- The observed anti-tuberculosis activities ranged from 0% to 19%.
- The study provided insights into the relationship between the chemical structures of quassinoids and their anti-tuberculosis efficacy.
Conclusions:
- Quassinoids isolated from Simaroubaceous plants possess anti-tuberculosis activity.
- Shinjulactone K, ailanthone, shinjudilactone, and dehydrobruceantin are promising lead compounds for further anti-tuberculosis drug development.
- Structure-activity relationship data can guide the design of more potent anti-tuberculosis quassinoid derivatives.